Finding Genius Podcast

Is someone pulling the wool over the country's eyes when it comes to the pros and cons of the inoculation? Informed consent is an important right to retain and may be the key to safely inoculating the population. Press play to learn: The number of inoculation suggested by the CDC How inoculation may have been shown to correlate with adverse side affects The social groups which are responsible for inoculation pressure Health freedom lawyer Greg Glaser shares his experience fighting for informed consent for a large population of civilians and doctors around the country, especially in the age of high-pressure inoculation. Inoculation have been an integral part of American society since the latter decades of the 1900s, regardless of whether they actually make people healthier. Unfortunately, due to the social pressure cultivated by years of high-profit marketing from the inoculation industry, the truth may not correlate with the information widely pushed in the media. The social constructs that have held inoculation status in paramount status for years now are also the same that cause the alienation and ridicule imposed by the inoculated population. However, this is reaching a fever pitch as mandatory inoculation have become increasingly popular among some political parties. Visit informedconsentdefense.org to learn more. Episode also available on Apple Podcasts: apple.co/30PvU9C

Dr. Abdul Kadir Slocum is a co-founder of Chemothermia, an oncology center in Turkey that combines conventional cancer treatments with “out-of-the-box” therapies to improve cancer treatment outcomes. Dr. Slocum began the clinic in 2010 in Turkey with two partners, Professor Bulent Berkarda, M.D., and Professor Mehmet Salih İyikesici, M.D. to treat cancer patients from around the world. Click on play to learn: What role cellular metabolism has in health. How diet, hyperthermia, and hyperbaric oxygen therapy maximise the efficacy and reduce the side effects of conventional treatments. How holistic treatments support the patient undergoing traditional cancer treatments with promising results. Dr. Slocum has been working with Dr. İyikesici and Dr. Berkarda on the development and application of conventional and unconventional cancer treatments such as oxygen therapy for cancer to support and balance the system. These supportive treatments give the patient more time to fight the disease. Therapies include metabolically supported chemotherapy, hyperthermia (local and whole body) therapy, hyperbaric oxygen therapy, and the ketogenic diet that all work synergistically with the standard conventional cancer treatments. Integrating the genetic and metabolic approaches with supportive strategies can maximise the efficacy of conventional treatments and reduce their side effects. Chemothermia claims to have one of the highest success rates in the world with their unique approach on cancer treatment. The clinic publishes their results in leading peer reviewed journals. Patients with stage 3 and stage 4 cancers can be treated at the clinic. Doctors develop personalized protocols for each patient treated at the clinic with promising results. To learn more visit: chemothermia.com Episode also available on Apple Podcasts: apple.co/30PvU9C

“This is one of the biggest stories ever,” says T. Colin Campbell.   What story is he talking about? The one that offers clear evidence of a safe, natural, and effective way to reverse cancer, diabetes, heart disease, and more. Tune in to discover: Whether there is a difference between the protein from pasture-fed animals and feedlot animals How taste preferences can change powerfully over a relatively short period of time Hidden sources of animal protein that you may not even know you consume Why most vegans still develop some of the same diseases as non-vegans and non-vegetarians T. Colin Campbell grew up on a farm, which meant growing up on dairy and animal meat. His doctoral dissertation was on the importance of animal protein consumption, and he even led a program in the Philippines aimed at helping malnourished children by providing them with quality animal proteins. His belief was firm, and in line with the rest of the nutritional science community: malnourishment results from inadequate amounts of quality protein from animal sources. But in reality, he encountered evidence which completely challenged this position: the Filipino children who were consuming animal protein like those in the Western world were at a higher risk of developing liver cancer. Animal studies showed the same thing: animals who consumed animal protein were more susceptible to the rapid growth of liver cancer. Campbell was faced with a dilemma: would he move forward with all the work he’d already promoted, or back up and carefully re-examine the evidence? He chose the latter, and received plenty of NIH funding to study whether animal protein really does cause cancer. The answer? An emphatic “Yes,” says Campbell. He has since published extensively on the topic and even served on government policy boards. “The further I got into this story and learned so much about it—not just about animal protein itself but also about the entire medical system and the way we actually tell the public the information we tell them—the more I realized there’s a serious problem here,” says Campbell. Heart disease, diabetes, and cancer are just a few of the diseases that can be treated and altogether reversed through a whole foods, plant-based diet. Interested in learning more? Press play, and visit https://nutritionstudies.org/. Episode also available on Apple Podcasts: apple.co/30PvU9C

How can early detection and regular monitoring of breast health play a significant role in the severity of breast cancer? The earlier cancer can be detected, a significant possibility emerges that an early understanding can benefit the patient when treatment begins. Listen in to learn: How heterogeneity impacts various tumors  If chemotherapy is contributing to tumors in specific ways How early-stage testing can save lives Professor of Medicine at Harvard Medical School and member of the Dana-Farber Cancer Institute, Kornelia Polyak, shares her research on the monitoring and preventing breast cancer. Through understanding why and when an individual gets breast cancer, better treatment techniques may become available, and prevention methods can be uncovered. In addition, through a deeper understanding of cause and early behavior, the next stages of treatment and prevention research can progress. The location of tumors and the environment within the body can play a significant part in determining the heterogeneity of cancer. This level of heterogeneity is one of the defining characteristics of how to treat and prevent tumors. For more information, visit polyaklab.dfci.harvard.edu. Episode also available on Apple Podcasts: apple.co/30PvU9C

Finally, you can take a deep breath in and relax…knowing you’ve also taken the lowest efficacious dose of your medicine, with less worry over adverse events. And it’s all thanks to a company called TFF Pharmaceuticals. Press play to learn: What specific problem TFF technology solves in terms of drug metabolism and systemic absorption How TFF technology can be applied to the area of vaccines Whether TFF technology could be used with cannabinoids as an alternative to vaping Glenn Mattes has worked in the pharmaceutical industry for over forty years now, and for the past four years, has served as CEO of TFF Pharmaceuticals, a Thin Film Freezing technology platform that can improve the properties of drug formulation, delivery, and administration while maintaining efficacy and avoiding many adverse events associated with other drug therapies. The Thin Film Freezing technology uses flash freezing to capture pharmaceutical drugs in a highly active state and convert them into highly concentrated powders. These powders can then be put into a capsule and inhaler device, allowing for administration directly into the lungs. Since the lung is an ideal organ for drug metabolism and distribution throughout the body, lower doses of the drug can be used to achieve the same or better efficacy with lower incidence of adverse events. Other substances being formulated at TFF Pharmaceuticals can be inhaled through the nose, and in the works is a formulation that can be applied to the eyes or skin. Mattes explains the science behind this technique, including the details of how and why it works, and the specific ways in which it can be applied. Learn more at https://tffpharma.com/. Episode also available on Apple Podcast: http://apple.co/30PvU9C

“When psychiatry became wedded with the drug companies, it became very little more than a sales department of the pharmaceutical industry,” says Dr. Peter Breggin. He explains the pre-wedding state, post-wedding state, the future of psychiatry, and how it’s all related to the current virus situation. Tune in to discover: What a lobotomy is, how it works, and how recently it’s been performed in the US Why various competing views in psychiatry have been reduced to one predominant viewpoint (and what that viewpoint is) The damaging side effects and deaths related to the vaccine for the current virus Dr. Breggin is a psychiatrist and author of over 20 books, with one of his most recent publications addressing the current virus situation and the influence of global predators. He’s been involved with reform work his whole life, starting with giant volunteer projects in state mental hospitals over 60 years ago, to taking on almost all major lobotomy programs in the US since then, and to this very day, trying to tackle electroshock therapy, and what he calls “chemical lobotomies” through psychiatric drugs. Dr. Breggin is the first psychiatrist to take various issues to the courtroom, and has been in trial over 100 times. Along the way, he’s been attacked and slandered by scientists, clinicians, fellow psychiatrists, and the medical-scientific establishment at large, but nonetheless remains firm in his stance against what he perceives to be unethical and even violent practices aimed at controlling humanity. In today’s show, he reveals these practices in detail and explains how they are intimately tied to the current virus situation. Tune in to hear the full conversation. Visit www.wearetheprey.com to check out his latest book and learn more. Episode also available on Apple Podcasts: apple.co/30PvU9C

“All malignant diseases are derived from a normal cell in the body,” says Dr. Owen O’Connor, MD, PhD. But how different are the malignant cells from the normal ones, and how hard is it to differentiate one from the other? This question is at the heart of the 'therapeutic window' problem in cancer treatment. But with new research in full swing, a solution may be within reach. Press play to learn: The four eras of cancer treatment, and where the future of cancer therapy is headed The problem of the therapeutic window and modern-day chemotherapies, and how a combination of immunotherapy and precision medicine could overcome it The function of B cells in the body; how they behave differently in malignant disease vs. autoimmune disease Dr. O’Connor is an international authority on lymphoma and drug development with over 25 years of experience in academic medicine. He is also Chief Scientific Officer at TG Therapeutics, a biotechnology company that focuses on targeting diseases related to underlying B cell dysfunction, like non-Hodgkin’s lymphoma and some autoimmune diseases. B cells are a type of white blood cell that produce antibodies designed to rid the body of pathogens. In lymphoma and some autoimmune diseases, however, these normal B cells begin wildly misbehaving or proliferating rapidly. In the case of malignant disease, the goal is to inhibit the proliferation of and kill these B cells; in the case of autoimmune disease, the goal is to suppress their activity and interactions with other cells in the body. How is this accomplished? And what’s wrong with most modern chemotherapies? Answering these questions leads Dr. O’Connor to discuss the meaning of the therapeutic window and two drugs that have been acquired and studied extensively by the team at TG Therapeutics. One of these drugs is an immunotherapy, and the other is a precision targeted therapy. The idea is that working together, these drugs could provide an effective treatment without the serious downsides of chemotherapies.  Visit https://www.tgtherapeutics.com/ to learn more.  Episode also available on Apple Podcasts: apple.co/30PvU9C

Kiana Aran, Ph.D. is an associate professor and director of the Aran Lab at Keck Institute and is also the Chief Scientific Officer at Cardea Bio. She is an electrical engineer with a driving interest in biology that has led her to combining these two seemingly unconnected fields. Her research has led to the discovery that amplification is not required for targeted DNA and gene detection. Click on play to learn: How functionalizing materials can be used in biosensing technologies and in lab-on-a-chip (LOC) systems. How linking biology directly with electronics molecular control signals can be accessed and studied. How the first DNA search engine is possible using a CRISPR-SNP-chip and graphene. Dr. Aran is interested in the integration electrical, mechanical, chemical, and bioengineering to develop new device solutions for use in clinical research. She thinks of the CRISPR chip as a microscopic robot that can be used as a genome typing tool, a kind of DNA search engine. This tool provides the ability to search through a complete genome in record time, among other things. Currently, the sensitivity of the platform is being evaluated and improved to allow for more types of research. Work is currently being conducted to assess the accuracy and efficiency of CRISPR itself. Research continues on combining the power of CRISPR in its search capabilities and the power of biology as a technology to facilitate research and new discoveries. To learn more visit: aranlab.org and cardeabio.com Episode also available on Apple Podcasts: apple.co/30PvU9C

A cure for cancer? Immunotherapy could be the key. Tune in to discover: How an antiviral response is similar to an anti-tumor response The various ways in which cancer evades the immune system Which immunotherapies can treat end-stage patients, and how they work Samantha Bucktrout is the senior director of research at Parker Institute for Cancer Immunotherapy, where she focuses on bringing curative immunotherapy for patients with cancer. She begins by explaining the basics of immunotherapy, noting that all throughout each and every day, our immune systems are at work detecting and eliminating pre-cancerous cells in the body. For patients who have developed metastasis and where the standard of care has failed, immunotherapy might provide promise. Research in immunology has led to an understanding of the ways in which cancer co-opts the body’s natural ability to regulate the immune system, and thereby actively blocks it from doing its job. Equipped with this knowledge, it’s possible to block the barriers put up by cancer through the use of antibodies. Immunotherapy, in some cases, can be considered to ‘cure’ patients who otherwise have fatal metastatic processes. Bucktrout discusses how chemotherapy affects the immune response, when it is used as the sole approach to cancer treatment as opposed to in conjunction with chemotherapy, how cancer cells may have evolved to evade the immune response, and much more. Press play to hear the full conversation and learn more at https://www.parkerici.org/. Episode also available on Apple Podcasts: apple.co/30PvU9C

“If you can’t sleep, so what?” asks Annie Miller. Well, you may or may not agree, but the point she’s making is that it’s far better to not care about a lack of sleep than to panic about it. Press play for more of her insights and learn: How different people are responding differently to the virus-related shutdowns and re-entry into the “old” way of life Why the bed should only be for sleeping Why eight hours of sleep isn’t best for everyone Annie Miller is a psychotherapist and the founder of DC Metro Sleep and Psychotherapy, a private practice in Bethesda, Maryland. Her specialties include sleep and insomnia, anxiety, trauma, and chronic pain. In today’s show, she discusses how the current virus situation has been impacting people’s anxiety and sleep health, and also explains her approach to helping people through these issues. In the process, she provides several tips on establishing and maintaining good sleep hygiene.   Tune in for all the details and visit https://dcmetrotherapy.com/ to learn more. Episode also available on Apple Podcasts: apple.co/30PvU9C